CSPC Pharmaceutical Group logo

CSPC Pharmaceutical Group

Asia, Hebei, China, Shijiazhuang

Description

CSPC Pharmaceutical Group is a pharmaceutical group in China.

Investor Profile

CSPC Pharmaceutical Group has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series B (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CSPC Pharmaceutical Group frequently co-invest with?

Daehwa Pharmaceutical
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
3H Health Investment
Asia, Hong Kong Island, Hong Kong, Cyberport
Co-Investments: 1
ALAN AMC
Asia, Beijing, China, Beijing
Co-Investments: 1
Huagai Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
CASVC
Asia, Beijing, China, Beijing
Co-Investments: 1
Atlas Capital LLC
North America, Arizona, United States, Phoenix
Co-Investments: 1
BioTrack Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Elite Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Yingke Capital
Asia, Jiangxi, China, Fuzhou
Co-Investments: 2

What are some of recent deals done by CSPC Pharmaceutical Group?

Yili Pharmaceutical is a pharmaceutical R&D company.

BiotechnologyHealth CareManufacturingPharmaceutical
AngelSep 25, 2025
Amount Raised: $14,039,423
Haihe Biopharma

Shanghai, Shanghai, China

Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BJul 24, 2020
Amount Raised: $171,005,942
Haihe Biopharma

Shanghai, Shanghai, China

Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BFeb 11, 2019
Amount Raised: $146,600,000

Find More Investors Like CSPC Pharmaceutical Group

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

CSPC Pharmaceutical Group | Pipeseed